➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Merck
Harvard Business School
Baxter
Mallinckrodt

Last Updated: April 17, 2021

DrugPatentWatch Database Preview

STERILE WATER FOR INJECTION Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Sterile Water For Injection, and when can generic versions of Sterile Water For Injection launch?

Sterile Water For Injection is a drug marketed by Fresenius Kabi Usa, Hospira, Medefil Inc, West-ward Pharms Int, B Braun, Baxter Hlthcare, Icu Medical Inc, and Taro. and is included in eleven NDAs.

The generic ingredient in STERILE WATER FOR INJECTION is sterile water for injection. There are one thousand and seventy-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sterile Water For Injection

A generic version of STERILE WATER FOR INJECTION was approved as sterile water for injection by HOSPIRA on October 27th, 1982.

  Start Trial

US Patents and Regulatory Information for STERILE WATER FOR INJECTION

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa STERILE WATER FOR INJECTION sterile water for injection LIQUID;N/A 209689-001 Nov 24, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa STERILE WATER FOR INJECTION IN PLASTIC CONTAINER sterile water for injection LIQUID;N/A 088400-001 Jan 16, 1984 AP RX No No   Start Trial   Start Trial   Start Trial
Medefil Inc STERILE WATER FOR INJECTION sterile water for injection LIQUID;N/A 211188-001 Dec 2, 2019 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Mallinckrodt
Dow
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.